RVL Pharmaceuticals (NASDAQ:RVLP) reported its Q1 earnings results on Thursday, May 11, 2023 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
RVL Pharmaceuticals reported in-line EPS of $-0.12 versus an estimate of $-0.12.
Revenue was down $12.61 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 2.8% increase in the share price the next day.
Here's a look at RVL Pharmaceuticals's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.16 | -0.14 | -0.21 |
| EPS Actual | -0.05 | -0.16 | -0.14 | -0.08 |
| Revenue Estimate | 12.60M | 10.22M | 8.52M | 7.44M |
| Revenue Actual | 9.81M | 10.02M | 8.45M | 21.44M |
To track all earnings releases for RVL Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
